The role of leukotriene modifying agent treatment in neuropsychiatric events of elderly asthma patients: a nested case control study

BACKGROUND: In March 2020, the US Food and Drug Administration decided that the dangers related to neuropsychiatric events (NPEs) of montelukast, one of the leukotriene modifying agents (LTMAs), should be communicated through ‘boxed warning’. In case of NPEs, the prevalence has been the highest in e...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Asthma Res Pract
Main Authors: Kang, Sang Oh, Min, Kyung Hyun, Kim, Hyun Jeong, Kim, Tae Hyeok, Kim, Woorim, Lee, Kyung Eun
Format: Artigo
Jezik:Inglês
Izdano: BioMed Central 2021
Teme:
Research
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC7972201/
https://ncbi.nlm.nih.gov/pubmed/33731203
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40733-021-00070-4
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki